Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI)

Infection ◽  
1984 ◽  
Vol 12 (6) ◽  
pp. 377-380 ◽  
Author(s):  
M. S. Sabbour ◽  
M. A. El Bokl ◽  
L. M. Osman
Keyword(s):  
Urinary Tract ◽  
Nalidixic Acid ◽  
Urinary Tract Infections ◽  
Oxolinic Acid ◽  
Efficacy And Safety ◽  
Tract Infections

Cinoxacin (cinobac) for urinary tract infections

1980 ◽  
Vol 18 (12) ◽  
pp. 47-48
Keyword(s):  
Urinary Tract ◽  
Nalidixic Acid ◽  
Urinary Tract Infections ◽  
Oxolinic Acid ◽  
Tract Infections

Cinoxacin (Cinobac - Lilly), a derivative of cinnolinic acid, is chemically related to nalidixic acid (Negram - Winthrop) and oxolinic acid,1 which is no longer marketed. Advantages of cinoxacin claimed by the manufacturer are a twice daily dosage and few and mild unwanted effects.

The Use of Nalidixic Acid in Urinary Tract Infections

1965 ◽  
Vol 20 (1) ◽  
pp. 12-16
Author(s):  
H. Beeuwkes ◽  
H. de Vries
Keyword(s):  
Urinary Tract ◽  
Nalidixic Acid ◽  
Urinary Tract Infections ◽  
Tract Infections

The Clinical Efficacy and Safety of Bacampicillin Twice Daily in Comparative Studies

1987 ◽  
Vol 15 (1) ◽  
pp. 32-43 ◽  
Author(s):  
M. Blomqvist ◽  
S. Å. Hedström
Keyword(s):  
Urinary Tract ◽  
Chronic Bronchitis ◽  
Urinary Tract Infections ◽  
Comparative Studies ◽  
Adverse Reactions ◽  
Low Frequency ◽  
Effective Dosage ◽  
Efficacy And Safety ◽  
Tract Infections ◽  
Dose Levels

In 16 controlled, randomized, comparative studies a total of 953 patients were treated for urinary tract infection, sinusitis, otitis media or chronic bronchitis. The aim was to evaluate the efficacy and safety of bacampicillin in a twice daily dosage, compared with three times daily dosages of bacampicillin, ampicillin, amoxycillin and a twice daily dosage of co-trimoxazole. Bacampicillin was given in amounts of either 400 or 800 mg to 422 of the patients in these studies. The twice daily dosage of bacampicillin eradicated 89% of the causative bacteria of urinary tract infections compared to 86% with the other regimens. In acute sinusitis 92% and 96% of the patients were either cured or improved when treated with 400 and 800 mg bacampicillin twice daily respectively. Similar percentages occurred in the groups given the three times daily dosages. In exacerbation of chronic bronchitis, 800 mg bacampicillin twice daily was the minimum effective dosage and 84% of the patients were either cured or improved with this regimen. Adverse drug reactions due to bacampicillin at all dose levels were less frequent than those of other anti-microbials. The lowest frequency of diarrhoea, 2.4%, was seen in the group given 400 mg bacampicillin twice daily. Dosages of 400 or 800 mg bacampicillin twice daily had a reliable efficacy combined with a low frequency of adverse reactions in respiratory and urinary tract infections.

OXOLINIC ACID IN THE TREATMENT OF URINARY TRACT INFECTIONS

1979 ◽  
Vol 1 (8) ◽  
pp. 345-347 ◽  
Author(s):  
Steven Kalowski ◽  
Priscilla Kincaid‐Smith ◽  
Robin Pavillard
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Oxolinic Acid ◽  
Tract Infections
Sign in / Sign up

Export Citation Format

Share Document